DK0914448T3 - Lipidkinase - Google Patents

Lipidkinase

Info

Publication number
DK0914448T3
DK0914448T3 DK97924137T DK97924137T DK0914448T3 DK 0914448 T3 DK0914448 T3 DK 0914448T3 DK 97924137 T DK97924137 T DK 97924137T DK 97924137 T DK97924137 T DK 97924137T DK 0914448 T3 DK0914448 T3 DK 0914448T3
Authority
DK
Denmark
Prior art keywords
kinase
p110delta
inositol
expression
melanomas
Prior art date
Application number
DK97924137T
Other languages
Danish (da)
English (en)
Inventor
Bart Vanhasebroeck
Michael Derek Waterfield
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Application granted granted Critical
Publication of DK0914448T3 publication Critical patent/DK0914448T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK97924137T 1996-06-01 1997-05-30 Lipidkinase DK0914448T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9611460.8A GB9611460D0 (en) 1996-06-01 1996-06-01 Novel lipid kinase
PCT/GB1997/001471 WO1997046688A1 (en) 1996-06-01 1997-05-30 Lipid kinase

Publications (1)

Publication Number Publication Date
DK0914448T3 true DK0914448T3 (da) 2007-02-12

Family

ID=10794609

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97924137T DK0914448T3 (da) 1996-06-01 1997-05-30 Lipidkinase

Country Status (14)

Country Link
US (4) US6482623B1 (zh)
EP (1) EP0914448B1 (zh)
JP (1) JP3902663B2 (zh)
CN (1) CN1260360C (zh)
AT (1) ATE342364T1 (zh)
AU (1) AU719354B2 (zh)
CA (1) CA2256483C (zh)
DE (1) DE69736807T2 (zh)
DK (1) DK0914448T3 (zh)
ES (1) ES2274543T3 (zh)
GB (1) GB9611460D0 (zh)
HK (1) HK1020751A1 (zh)
NZ (1) NZ332634A (zh)
WO (1) WO1997046688A1 (zh)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9611460D0 (en) * 1996-06-01 1996-08-07 Ludwig Inst Cancer Res Novel lipid kinase
US5858753A (en) * 1996-11-25 1999-01-12 Icos Corporation Lipid kinase
AU781078B2 (en) * 1996-11-25 2005-05-05 Icos Corporation Phosphatidylinositol 3-kinase P110 delta catalytic subunit
AU2005201060B2 (en) * 1996-11-25 2007-06-21 Icos Corporation Phosphatidylinositol 3-kinase P110 Delta Catalytic Subunit
DE19860833C1 (de) 1998-12-30 2000-09-07 Albrecht E Sippel Methode zur zellulären High-Throughput(Hochdurchsatz)-Detektion von Rezeptor-Liganden-Interaktionen
US6046049A (en) * 1999-07-19 2000-04-04 Isis Pharmaceuticals Inc. Antisense modulation of PI3 kinase p110 delta expression
EP1242616A2 (en) * 1999-12-06 2002-09-25 Axxima Pharmaceuticals Aktiengesellschaft Method for identification and quantification of kinase inhibitors
CN1314480A (zh) * 2000-03-22 2001-09-26 上海博德基因开发有限公司 一种新的多肽——人磷脂酰肌醇3激酶14和编码这种多肽的多核苷酸
EP1939203B1 (en) 2000-04-25 2014-11-19 ICOS Corporation Inhibitors of human phosphatidyl-inositol 3-kinase delta isoform
MXPA02010618A (es) * 2000-04-25 2004-05-05 Icos Corp Inhibidores de fosfatidilinositol 3-quinasa delta.
US6667300B2 (en) 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
AU2001265231B2 (en) * 2000-05-31 2006-07-06 Promega Corporation Assay for kinases and phosphatases
US7067269B2 (en) * 2001-11-26 2006-06-27 Echelon Biosciences, Inc. Assaying apparatus, kit, and method for lipids and associated enzymes
US20050009124A1 (en) * 2001-11-26 2005-01-13 Echelon Biosciences Incorporated Assays for detection of phosphoinositide kinase and phosphatase activity
DE10232723A1 (de) * 2002-07-16 2004-02-05 MedInnova Gesellschaft für medizinische Innovationen aus akademischer Forschung mbH Testsystem zur Auffindung von Inhibitoren von Inositolphosphatkinasen und Verwendungen dieser Inhibitoren für die Prophylaxe oder Therapie von proliferativen Erkrankungen
US7429596B2 (en) * 2003-06-20 2008-09-30 The Regents Of The University Of California 1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof
US20050043239A1 (en) * 2003-08-14 2005-02-24 Jason Douangpanya Methods of inhibiting immune responses stimulated by an endogenous factor
ES2605792T3 (es) 2004-05-13 2017-03-16 Icos Corporation Quinazolinona usada como inhibidor de la fosfatidilinositol 3-quinasa delta humana
CA2567883A1 (en) * 2004-05-25 2005-12-15 Icos Corporation Methods for treating and/or preventing aberrant proliferation of hematopoietic cells
EP1831225A2 (en) 2004-11-19 2007-09-12 The Regents of the University of California Anti-inflammatory pyrazolopyrimidines
CA2598409A1 (en) * 2005-02-17 2006-08-24 Icos Corporation Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
EA200870409A1 (ru) 2006-04-04 2009-04-28 Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния Антагонисты киназы pi3
US7547760B2 (en) * 2006-07-03 2009-06-16 West Virginia University Peptides and chemical compound for inhibition of SHP2 function
JP5313909B2 (ja) 2006-11-13 2013-10-09 アイコス コーポレイション 炎症性疾患および癌の処置のためのチエノピリミジノン
MX2009009968A (es) 2007-03-23 2009-10-08 Amgen Inc Compuestos heterociclicos y sus usos.
WO2009046448A1 (en) * 2007-10-04 2009-04-09 Intellikine, Inc. Chemical entities and therapeutic uses thereof
US8193182B2 (en) 2008-01-04 2012-06-05 Intellikine, Inc. Substituted isoquinolin-1(2H)-ones, and methods of use thereof
MX2010007418A (es) 2008-01-04 2010-11-12 Intellikine Inc Ciertas entidades quimicas, composiciones y metodos.
US8993580B2 (en) 2008-03-14 2015-03-31 Intellikine Llc Benzothiazole kinase inhibitors and methods of use
US8637542B2 (en) 2008-03-14 2014-01-28 Intellikine, Inc. Kinase inhibitors and methods of use
US20110224223A1 (en) * 2008-07-08 2011-09-15 The Regents Of The University Of California, A California Corporation MTOR Modulators and Uses Thereof
BRPI0915231A2 (pt) 2008-07-08 2018-06-12 Intellikine Inc compostos inibidores de quinase e métodos de uso
WO2010036380A1 (en) 2008-09-26 2010-04-01 Intellikine, Inc. Heterocyclic kinase inhibitors
DK2358720T3 (en) 2008-10-16 2016-06-06 Univ California Heteroarylkinaseinhibitorer fused-ring
US8476282B2 (en) 2008-11-03 2013-07-02 Intellikine Llc Benzoxazole kinase inhibitors and methods of use
US9492449B2 (en) 2008-11-13 2016-11-15 Gilead Calistoga Llc Therapies for hematologic malignancies
WO2010057048A1 (en) 2008-11-13 2010-05-20 Calistoga Pharmaceuticals Inc. Therapies for hematologic malignancies
US20120039905A1 (en) * 2009-01-13 2012-02-16 The Babraham Institute The Role of p110 delta Signaling in Morbidity and Lung Pathology Induced by Influenza Virus Infection
CN102439012A (zh) 2009-03-24 2012-05-02 吉里德卡利斯托加公司 2-嘌呤基-3-甲苯基-喹唑啉酮衍生物的阻转异构体和使用方法
KR20120005523A (ko) * 2009-04-20 2012-01-16 길리아드 칼리스토가 엘엘씨 고형 종양의 치료 방법
CA2760791C (en) 2009-05-07 2017-06-20 Intellikine, Inc. Heterocyclic compounds and uses thereof
JP2012531435A (ja) 2009-06-25 2012-12-10 アムジエン・インコーポレーテツド ＰＩ３Ｋ阻害剤としての４Ｈ−ピリド［１，２−ａ］ピリミジン−４−オン誘導体
US8765940B2 (en) 2009-06-25 2014-07-01 Amgen Inc. Heterocyclic compounds and their uses
MX2011013666A (es) 2009-06-25 2012-03-06 Amgen Inc Compuestos heterociclicos y sus usos.
AR077267A1 (es) 2009-06-25 2011-08-17 Amgen Inc Derivados nitrogenados heterociclicos inhibidores selectivos de pi3k, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades inflamatorias y/o autoinmunes.
AU2010276160A1 (en) 2009-07-21 2012-02-09 Gilead Calistoga Llc Treatment of liver disorders with PI3K inhibitors
US8980899B2 (en) 2009-10-16 2015-03-17 The Regents Of The University Of California Methods of inhibiting Ire1
EP2513109A1 (en) 2009-12-18 2012-10-24 Amgen Inc. Heterocyclic compounds and their uses
UY33304A (es) 2010-04-02 2011-10-31 Amgen Inc Compuestos heterocíclicos y sus usos
EP2571357B1 (en) 2010-05-21 2016-07-06 Infinity Pharmaceuticals, Inc. Chemical compounds, compositions and methods for kinase modulation
WO2012003278A1 (en) 2010-06-30 2012-01-05 Amgen Inc. Quinolines as p13k inhibitors
WO2012003283A1 (en) 2010-06-30 2012-01-05 Amgen Inc. Heterocyclic compounds and their use as inhibitors of pi3k activity
CA2803620A1 (en) 2010-06-30 2012-01-05 Amgen Inc. Heterocyclic compounds and their uses
EP2588467A1 (en) 2010-07-01 2013-05-08 Amgen Inc. Heterocyclic compounds and their use as inhibitors of pi3k activity
ES2472720T3 (es) 2010-07-01 2014-07-02 Amgen Inc. Compuestos heteroc�clicos y su uso como inhibidores de actividad PI3K
AU2011272850A1 (en) 2010-07-02 2013-01-10 Amgen Inc. Heterocyclic compounds and their use as inhibitors of PI3K activity
MX2013005005A (es) 2010-11-04 2013-10-25 Amgen Inc Derivados de ciano-4,6-diaminopirimidina o 6-aminopurina como inhibidores de pi3k-delta.
WO2012064973A2 (en) 2010-11-10 2012-05-18 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
EP2640715A1 (en) 2010-11-17 2013-09-25 Amgen Inc. Quinoline derivatives as pik3 inhibitors
CA2822590A1 (en) 2010-12-23 2012-06-28 Amgen Inc. Heterocyclic compounds and their uses
AR084824A1 (es) 2011-01-10 2013-06-26 Intellikine Inc Procesos para preparar isoquinolinonas y formas solidas de isoquinolinonas
AR085397A1 (es) 2011-02-23 2013-09-25 Intellikine Inc Combinacion de inhibidores de quinasa y sus usos
AU2012284088B2 (en) 2011-07-19 2015-10-08 Infinity Pharmaceuticals Inc. Heterocyclic compounds and uses thereof
CN103946226A (zh) 2011-07-19 2014-07-23 无限药品股份有限公司 杂环化合物及其应用
WO2013032591A1 (en) 2011-08-29 2013-03-07 Infinity Pharmaceuticals Inc. Heterocyclic compounds and uses thereof
AU2012341028C1 (en) 2011-09-02 2017-10-19 Mount Sinai School Of Medicine Substituted pyrazolo[3,4-D]pyrimidines and uses thereof
ES2848273T3 (es) 2012-03-05 2021-08-06 Gilead Calistoga Llc Formas polimórficas de (S)-2-(1-(9H-purin-6-ilamino)propilo)-5-fluoro-3-fenilquinazolina-4(3H)-ona
PE20142457A1 (es) 2012-04-04 2015-02-07 Amgen Inc Compuestos heterociclicos y sus usos
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US8828998B2 (en) 2012-06-25 2014-09-09 Infinity Pharmaceuticals, Inc. Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
WO2014052669A1 (en) 2012-09-26 2014-04-03 The Regents Of The University Of California Modulation of ire1
AU2013364070B2 (en) 2012-12-21 2016-10-27 Gilead Calistoga Llc Isoquinolinone or quinazolinone phosphatidylinositol 3-kinase inhibitors
TW201441216A (zh) 2012-12-21 2014-11-01 Gilead Calistoga Llc 肌醇磷酯３－激酶的抑制劑
US9481667B2 (en) 2013-03-15 2016-11-01 Infinity Pharmaceuticals, Inc. Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
MX347988B (es) 2013-06-14 2017-05-19 Gilead Sciences Inc Inhibidores de fosfatidilinositol 3-cinasa.
WO2015051241A1 (en) 2013-10-04 2015-04-09 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
JP6466924B2 (ja) 2013-10-04 2019-02-06 インフィニティー ファーマシューティカルズ， インコーポレイテッド 複素環式化合物及びその使用
AU2014364414A1 (en) 2013-12-20 2016-06-30 Gilead Calistoga Llc Polymorphic forms of a hydrochloride salt of (S) -2-(1-(9H-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3H) -one
SG11201604825VA (en) 2013-12-20 2016-07-28 Gilead Calistoga Llc Process methods for phosphatidylinositol 3-kinase inhibitors
US9775844B2 (en) 2014-03-19 2017-10-03 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US20150320755A1 (en) 2014-04-16 2015-11-12 Infinity Pharmaceuticals, Inc. Combination therapies
KR20170012560A (ko) 2014-06-13 2017-02-02 길리애드 사이언시즈, 인코포레이티드 포스파티딜이노시톨 3-키나제 억제제
CN104155440B (zh) * 2014-07-16 2016-02-10 广东药学院 p110δ及其抗体在特异性标记滋养层巨细胞（pTGC）中的应用
US9708348B2 (en) 2014-10-03 2017-07-18 Infinity Pharmaceuticals, Inc. Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
CA2998469A1 (en) 2015-09-14 2017-03-23 Infinity Pharmaceuticals, Inc. Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same
WO2017161116A1 (en) 2016-03-17 2017-09-21 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
US10919914B2 (en) 2016-06-08 2021-02-16 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
SG11201811237WA (en) 2016-06-24 2019-01-30 Infinity Pharmaceuticals Inc Combination therapies
US20240075093A1 (en) * 2020-10-09 2024-03-07 Virginia Tech Intellectual Properties, Inc. Compositions and methods of treating a pi3k mediated disease

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992788A (en) * 1975-07-14 1976-11-23 Orien William P Insole and outsole construction for athletic (tennis) shoes, and the like
US4603698A (en) * 1984-05-09 1986-08-05 Jaime Guttmann Cherniak System of podiatric appliances independently adjustably securable on inner sole-like base plate
GB8609998D0 (en) * 1986-04-24 1986-05-29 Andrews A C Insoles for footwear
US4841648A (en) * 1988-02-29 1989-06-27 Shaffer David E Personalized insole kit
GB9208135D0 (en) * 1992-04-13 1992-05-27 Ludwig Inst Cancer Res Polypeptides having kinase activity,their preparation and use
GB9611460D0 (en) * 1996-06-01 1996-08-07 Ludwig Inst Cancer Res Novel lipid kinase
KR0173096B1 (ko) * 1996-11-11 1999-01-15 박인식 발 교정용 안창
US5858753A (en) * 1996-11-25 1999-01-12 Icos Corporation Lipid kinase
US6393736B1 (en) * 2000-05-25 2002-05-28 Greer Reed Biomedical, Llc Adjustable brace orthotic and method of treating plantar fasciitis and related foot disorders
US6557273B2 (en) * 2001-09-28 2003-05-06 Joseph Paul Polifroni Layered arch support and method of manufacture
US6854199B2 (en) * 2001-09-28 2005-02-15 Joseph Paul Polifroni Layered arch support
US7124520B2 (en) * 2002-01-18 2006-10-24 Pittsburgh Plastics Manufacturing, Inc. Footwear insoles
JP2004031574A (ja) * 2002-06-25 2004-01-29 Fuji Photo Film Co Ltd プラスチックファイバーを用いた伝送装置
US20040194344A1 (en) * 2003-04-05 2004-10-07 Tadin Anthony G. User-customizable insoles for footwear and method of customizing insoles
US7210250B2 (en) * 2005-06-07 2007-05-01 Gallegos Alvaro Z Multipiece footwear insole
US20070043582A1 (en) * 2005-08-22 2007-02-22 Fila Luxembourg S.A.R.L. Method and system for providing customized footwear to a retail consumer
US7900380B2 (en) * 2005-10-13 2011-03-08 Masterfit Enterprises Inc. User moldable adjustable insert

Also Published As

Publication number Publication date
JP3902663B2 (ja) 2007-04-11
AU719354B2 (en) 2000-05-04
EP0914448A1 (en) 1999-05-12
GB9611460D0 (en) 1996-08-07
CA2256483C (en) 2010-06-22
HK1020751A1 (en) 2000-05-19
EP0914448B1 (en) 2006-10-11
ES2274543T3 (es) 2007-05-16
WO1997046688A1 (en) 1997-12-11
CA2256483A1 (en) 1997-12-11
US6849420B2 (en) 2005-02-01
US20060018893A1 (en) 2006-01-26
AU2970597A (en) 1998-01-05
NZ332634A (en) 2000-09-29
DE69736807T2 (de) 2007-08-16
CN1260360C (zh) 2006-06-21
JP2000517165A (ja) 2000-12-26
US6482623B1 (en) 2002-11-19
US7422886B2 (en) 2008-09-09
DE69736807D1 (en) 2006-11-23
US20050064572A1 (en) 2005-03-24
US20030099627A1 (en) 2003-05-29
CN1220701A (zh) 1999-06-23
ATE342364T1 (de) 2006-11-15

Similar Documents

Publication Publication Date Title
DK0914448T3 (da) Lipidkinase
ATE396978T1 (de) Triazin-kinase-hemmer
EA200201096A1 (ru) СОЕДИНЕНИЯ ПИРРОЛО[2,3-d]ПИРИМИДИНА В КАЧЕСТВЕ ИММУНОДЕПРЕССАНТОВ
DE60229975D1 (de) Nf-kb-inhibitoren
ATE425160T1 (de) Benzisoxazolderivate, die sich als inhibitoren von proteinkinasen eigen
CY1105618T1 (el) Δικυκλικες ετεροαρωματικες ενωσεις ως αναστολεις της κινασης τυροσινης πρωτεϊνης
TR200001174T2 (tr) Protein tirozin kinaz ve protein serin/treonin kinaz inhibitörleri olarak ikameli oksindol türevleri
NO974457L (no) Inhibitorer for farnesylproteintransferase
TR200101858T2 (tr) JNK protein kinaz inhibitörleri olarak 4-ariloksindoller
NO20020467D0 (no) Purinderivater inhibitorer av tyrosin proteinkinase syk
TR199800773T2 (xx) Trombin inhibit�rleri.
ATE164593T1 (de) Aminoacetylmercaptoacetylamid derivate mit enkephalinase- und ace-hemmwirkung
ATE407132T1 (de) Inhibitoren von c-jun n-terminalen kinasen (jnk) und anderen proteinkinasen
ATE426662T1 (de) Feedback resistante mevalonate kinase
BR9706792A (pt) Derivado de tiazol
ATE482938T1 (de) Tyrosinkinaseinhibitoren
CY1109596T1 (el) Αναστολεις φωσφατασων cdc25
BR0209149A (pt) Ftalazinonas
DE60230017D1 (de) Farnesyl-protein-transferase hemmer in kombination mit antiöstrogenen
DK0500602T3 (da) Middel til neutralisering af til tumorceller knyttet prokoagulantaktivitet
DE60312997D1 (de) Nf-kb-inhibitoren
CY1105269T1 (el) Συνδυασμενη θepαπεια εναντι ογκων που πepιλαμβανει υποκατεστημενα παραγωγα ακρυλοϋλ δισταμυκινης και αναστολεις κινασης πρωτεϊνης (κιναση σepινης/θρεονινης)
DE69534118D1 (de) Verwendung der no-faenger, inhibitoren oder antagonisten zur behandlung von migraene
DE60316423D1 (de) Tyrosinkinase-hemmer
ATE536181T1 (de) Metabolite von wortmannin-analogen und verwendungsverfahren dafür